Smart breath testing for COPD-management.
To predict lung attacks and improve health outcomes.
Daily breath monitoring: Empower your COPD patients to manage their health.
There are many uncertainties for people living with COPD. A lung attack can occur at any given moment and existing tests often indicated it too late.
RespiQ’s smart breath testing will enable patients to easily monitor their health, provide instant health insights and have more control over their disease. Empowering them to diminish uncertainties, stay healthier and spend more time enjoying their lives.
RespiQ is developing a breathalyser that will offer a non-invasive health monitoring solution patients can easily use themselves at home as well as point of care. Clinicians can remotely review patients’ data which will allow for earlier medical intervention with the aim to prevent lung attacks.
Nearly 1 in 8 adults suffer from COPD.
COPD Patients can experience lung attacks, triggered by inflammation in the lungs. This inflammation releases molecules that can be detected in the breath.
How it works
Our handheld breathalyser will be able to check your patients’ breath daily for biomarkers that disclose an impending exacerbation, allowing for early clinical intervention with the aim to prevent a lung attack.
Easy to use
In the comfort of home or at point of care
Smart Analysis
Smart predictive algorithms analyse the breath instantly aiming to prevent exacerbations
Remote access
Remote access to data allows for daily patient monitoring
Early intervention
Even the smallest changes are highlighted which allows for earlier intervention
Better wellbeing
Engaging and empowering patients to improve their wellbeing
Faster testing. Smarter analysis. Better wellbeing.
Results you can feel.
Our Science explained
Faster testing
A lung attack is often triggered by inflammation in the lungs. When the lungs are inflamed certain molecules are produced. These molecules can be detected in the breath as ‘biomarkers’.
Our precision technology will be able to accurately measure these disease biomarker concentrations in patients’ breath. It will instantly detect the tiniest changes thanks to its high sensitivity, indicating a patients’ lung health might be compromised.
Smarter analysis.
Once the breathalyser measures the presence and concentrations of biomarkers a unique breathprint will be created. Our proprietary algorithm will analyse this breathprint to create personal health insight. These details are instantly shared for clinicians’ analysis.
Repeating this on a daily basis will allow both clinician and patient to monitor changes and manage their health effectively.
Better wellbeing.
By monitoring patients’ breath on a daily basis, they are warned of an impending inflammation before symptoms occur. This will allow for earlier medical intervention with the aim to prevent an exacerbation.
Patients’ control and their personalized treatment will empower them to keep monitoring their health and improve overall wellbeing.
COPD facts
According to the World Health Organization COPD is the third leading cause of death worldwide.
Research shows that nearly 1 in 8 adults suffer from COPD
It also shows 18% of patients cause 65% of COPD hospitalizations
Lung attacks are mostly driven by viral or bacterial airway infection, accelerate lung function decline and have a negative impact on quality of life.
